Status
Conditions
Treatments
About
OZURDEX endophthalmitis is a rare and potentially very serious pathology. Different treatments can be carried out early and change the functional prognosis of the patient.
Enrollment
Sex
Volunteers
Inclusion criteria
Exclusion criteria
8 participants in 1 patient group
Loading...
Central trial contact
Thibaud GARCIN, MD PhD; Henri PITEAU, resident
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal